
LINK . SPRINGER . COM {
}
Title:
Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance | Gastric Cancer
Description:
Background The attainment of drug resistance in gastric cancer (GC) is a problematic issue. Although many studies have shown that cancer stem cells (CSCs) play an important role in the acquisition of drug resistance, there is no clinically available biomarker for predicting oxaliplatin (L-OHP) resistance in relation to CSCs. Organoid technology, a novel 3D cell culture system, allows harboring of patient-derived cancer cells containing abundant CSCs using niche factors in a dish. Methods In this study, we established L-OHP-resistant gastric cancer organoids (GCOs) and evaluated their gene expression profile using microarray analysis. We validated the upregulated genes in the L-OHP-resistant GCOs compared to their parental GCOs to find a gene responsible for L-OHP resistance by qRT-PCR, immunohistochemistry, in vitro, and in vivo experiments. Results We found myoferlin (MYOF) to be a candidate gene through microarray analysis. The results from cell viability assays and qRT-PCR showed that high expression of MYOF correlated significantly with the IC50 of L-OHP in GCOs. Immunohistochemistry of MYOF in GC tissue samples revealed that high expression of MYOF was significantly associated with poor prognosis, T grade, N grade, and lymphatic invasion, and showed MYOF to be an independent prognostic indicator, especially in the GC patients treated with platinum-based chemotherapy. The knockdown of MYOF repressed L-OHP resistance, cell growth, stem cell features, migration, invasion, and in vivo tumor growth. Conclusions Our results suggest that MYOF is highly involved in L-OHP resistance and tumor progression in GC. MYOF could be a promising biomarker and therapeutic target for L-OHP-resistant GC cases.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Education
- Science
- Health & Fitness
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We can't tell how the site generates income.
Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.
Keywords {🔍}
myof, gcos, lohp, cancer, expression, cell, fig, lohpresistant, cells, article, resistance, gastric, supplementary, google, scholar, analysis, organoids, tumor, assay, test, mkn, lines, cas, organoid, parental, invasion, patients, student, cscs, showed, cases, performed, gene, genes, results, growth, human, hiroshima, table, levels, data, research, myoferlin, shown, study, microarray, migration, normal, size, survival,
Topics {✒️}
r-spondin-producing cell line l-ohp-based therapeutic outcomes l-ohp-resistant gcos compared l-ohp-resistant gcos transduced k24 l-ohp-resistant gcos independent l-ohp-resistant gcos establish l-ohp-resistant gcos l-ohp-resistant gcos exhibited dna-damaging anti-cancer drugs k24 l-ohp-resistant gco l-ohp-resistant gc cases l-ohp-based treatment response stem cell-related markers patient-derived cancer cells exerts anti-tumor effects liver-intestine cadherin induction receiving platinum-based chemotherapy l-ohp-resistant gcos alter l-ohp sensitivity overcome l-ohp resistance approach l-ohp resistance reflects l-ohp resistance csc/epithelial-mesenchymal transition l-ohp-resistant gco received platinum-based chemotherapy receive platinum-based therapy dab substrate-chromogen solution human genome/gene research l-ohp administration timeline l-ohp treatment leads l-ohp gastric cscs l-ohp-resistant cscs drug-resistant cancer organoids cancer stem cell envision + anti-mouse full size image cancer stem cells phase-contrast microscopy anti-rabbit peroxidase triple-negative breast cancer l-ohp exerts cell stem cell organoid-based preclinical model elucidated 5-fu-resistant gcos kaplan–meier plotter database living organoid biobank human gastric cancer sustain stem cells gene expression profile l-ohp-resistant
Schema {🗺️}
WebPage:
mainEntity:
headline:Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance
description:The attainment of drug resistance in gastric cancer (GC) is a problematic issue. Although many studies have shown that cancer stem cells (CSCs) play an important role in the acquisition of drug resistance, there is no clinically available biomarker for predicting oxaliplatin (L-OHP) resistance in relation to CSCs. Organoid technology, a novel 3D cell culture system, allows harboring of patient-derived cancer cells containing abundant CSCs using niche factors in a dish. In this study, we established L-OHP-resistant gastric cancer organoids (GCOs) and evaluated their gene expression profile using microarray analysis. We validated the upregulated genes in the L-OHP-resistant GCOs compared to their parental GCOs to find a gene responsible for L-OHP resistance by qRT-PCR, immunohistochemistry, in vitro, and in vivo experiments. We found myoferlin (MYOF) to be a candidate gene through microarray analysis. The results from cell viability assays and qRT-PCR showed that high expression of MYOF correlated significantly with the IC50 of L-OHP in GCOs. Immunohistochemistry of MYOF in GC tissue samples revealed that high expression of MYOF was significantly associated with poor prognosis, T grade, N grade, and lymphatic invasion, and showed MYOF to be an independent prognostic indicator, especially in the GC patients treated with platinum-based chemotherapy. The knockdown of MYOF repressed L-OHP resistance, cell growth, stem cell features, migration, invasion, and in vivo tumor growth. Our results suggest that MYOF is highly involved in L-OHP resistance and tumor progression in GC. MYOF could be a promising biomarker and therapeutic target for L-OHP-resistant GC cases.
datePublished:2021-07-16T00:00:00Z
dateModified:2021-07-30T00:00:00Z
pageStart:1264
pageEnd:1277
sameAs:https://doi.org/10.1007/s10120-021-01206-4
keywords:
Organoids
Oxaliplatin
Gastric cancer
MYOF
Surgical Oncology
Oncology
Abdominal Surgery
Gastroenterology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig5_HTML.png
isPartOf:
name:Gastric Cancer
issn:
1436-3305
1436-3291
volumeNumber:24
type:
Periodical
PublicationVolume
publisher:
name:Springer Singapore
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Kenji Harada
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Naoya Sakamoto
url:http://orcid.org/0000-0001-6273-0189
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Shoichi Ukai
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Yusuke Yamamoto
affiliation:
name:National Cancer Center Research Institute
address:
name:Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Quoc Thang Pham
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Daiki Taniyama
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Ririno Honma
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Ryota Maruyama
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Tsuyoshi Takashima
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Hiroshi Ota
affiliation:
name:Hiroshima University
address:
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Yuki Takemoto
affiliation:
name:Hiroshima University
address:
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Kazuaki Tanabe
affiliation:
name:Hiroshima University
address:
name:Department of Health Care for Adults, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Hideki Ohdan
affiliation:
name:Hiroshima University
address:
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Wataru Yasui
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance
description:The attainment of drug resistance in gastric cancer (GC) is a problematic issue. Although many studies have shown that cancer stem cells (CSCs) play an important role in the acquisition of drug resistance, there is no clinically available biomarker for predicting oxaliplatin (L-OHP) resistance in relation to CSCs. Organoid technology, a novel 3D cell culture system, allows harboring of patient-derived cancer cells containing abundant CSCs using niche factors in a dish. In this study, we established L-OHP-resistant gastric cancer organoids (GCOs) and evaluated their gene expression profile using microarray analysis. We validated the upregulated genes in the L-OHP-resistant GCOs compared to their parental GCOs to find a gene responsible for L-OHP resistance by qRT-PCR, immunohistochemistry, in vitro, and in vivo experiments. We found myoferlin (MYOF) to be a candidate gene through microarray analysis. The results from cell viability assays and qRT-PCR showed that high expression of MYOF correlated significantly with the IC50 of L-OHP in GCOs. Immunohistochemistry of MYOF in GC tissue samples revealed that high expression of MYOF was significantly associated with poor prognosis, T grade, N grade, and lymphatic invasion, and showed MYOF to be an independent prognostic indicator, especially in the GC patients treated with platinum-based chemotherapy. The knockdown of MYOF repressed L-OHP resistance, cell growth, stem cell features, migration, invasion, and in vivo tumor growth. Our results suggest that MYOF is highly involved in L-OHP resistance and tumor progression in GC. MYOF could be a promising biomarker and therapeutic target for L-OHP-resistant GC cases.
datePublished:2021-07-16T00:00:00Z
dateModified:2021-07-30T00:00:00Z
pageStart:1264
pageEnd:1277
sameAs:https://doi.org/10.1007/s10120-021-01206-4
keywords:
Organoids
Oxaliplatin
Gastric cancer
MYOF
Surgical Oncology
Oncology
Abdominal Surgery
Gastroenterology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig5_HTML.png
isPartOf:
name:Gastric Cancer
issn:
1436-3305
1436-3291
volumeNumber:24
type:
Periodical
PublicationVolume
publisher:
name:Springer Singapore
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Kenji Harada
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Naoya Sakamoto
url:http://orcid.org/0000-0001-6273-0189
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Shoichi Ukai
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Yusuke Yamamoto
affiliation:
name:National Cancer Center Research Institute
address:
name:Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Quoc Thang Pham
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Daiki Taniyama
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Ririno Honma
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Ryota Maruyama
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Tsuyoshi Takashima
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Hiroshi Ota
affiliation:
name:Hiroshima University
address:
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Yuki Takemoto
affiliation:
name:Hiroshima University
address:
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Kazuaki Tanabe
affiliation:
name:Hiroshima University
address:
name:Department of Health Care for Adults, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Hideki Ohdan
affiliation:
name:Hiroshima University
address:
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Wataru Yasui
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Gastric Cancer
issn:
1436-3305
1436-3291
volumeNumber:24
Organization:
name:Springer Singapore
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
name:National Cancer Center Research Institute
address:
name:Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan
type:PostalAddress
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
name:Hiroshima University
address:
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
name:Hiroshima University
address:
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
name:Hiroshima University
address:
name:Department of Health Care for Adults, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
name:Hiroshima University
address:
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Kenji Harada
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
name:Naoya Sakamoto
url:http://orcid.org/0000-0001-6273-0189
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
email:[email protected]
name:Shoichi Ukai
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
name:Yusuke Yamamoto
affiliation:
name:National Cancer Center Research Institute
address:
name:Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan
type:PostalAddress
type:Organization
name:Quoc Thang Pham
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
name:Daiki Taniyama
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
name:Ririno Honma
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
name:Ryota Maruyama
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
name:Tsuyoshi Takashima
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
name:Hiroshi Ota
affiliation:
name:Hiroshima University
address:
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
name:Yuki Takemoto
affiliation:
name:Hiroshima University
address:
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
name:Kazuaki Tanabe
affiliation:
name:Hiroshima University
address:
name:Department of Health Care for Adults, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
name:Hideki Ohdan
affiliation:
name:Hiroshima University
address:
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
name:Wataru Yasui
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
PostalAddress:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
name:Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
name:Department of Health Care for Adults, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
External Links {🔗}(121)
- What are the earnings of https://www.springernature.com/gp/authors?
- What's the total monthly financial gain of https://link.springernature.com/home/?
- What's the monthly income of https://order.springer.com/public/cart?
- https://www.editorialmanager.com/gcan income
- How much does https://orcid.org/0000-0001-6273-0189 rake in every month?
- Learn about the earnings of https://beta.springernature.com/pre-submission?journalId=10120
- How much income is http://gepia.cancer-pku.cn earning monthly?
- What's the financial intake of http://www.kmplot.com?
- What are the earnings of http://gepia.cancer-pku.cn/?
- How much does https://doi.org/10.3322%2Fcaac.21492 make?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Global%20cancer%20statistics%202018%3A%20GLOBOCAN%20estimates%20of%20incidence%20and%20mortality%20worldwide%20for%2036%20cancers%20in%20185%20countries&journal=CA%20Cancer%20J%20Clin&doi=10.3322%2Fcaac.21492&volume=68&pages=394-424&publication_year=2018&author=Bray%2CF&author=Ferlay%2CJ&author=Soerjomataram%2CI&author=Siegel%2CRL&author=Torre%2CLA&author=Jemal%2CA each month?
- What's the financial gain of https://doi.org/10.1038%2Fnrc3599?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Cancer%20drug%20resistance%3A%20an%20evolving%20paradigm&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc3599&volume=13&pages=714-26&publication_year=2013&author=Holohan%2CC&author=Schaeybroeck%2CS&author=Longley%2CDB&author=Johnston%2CPG?
- Check the income stats for https://doi.org/10.1038%2Fnrclinonc.2017.44
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=EMT%2C%20CSCs%2C%20and%20drug%20resistance%3A%20the%20mechanistic%20link%20and%20clinical%20implications&journal=Nat%20Rev%20Clin%20Oncol&doi=10.1038%2Fnrclinonc.2017.44&volume=14&pages=611-629&publication_year=2017&author=Shibue%2CT&author=Weinberg%2CRA?
- How profitable is https://doi.org/10.1016%2Fj.cell.2014.12.021?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Organoid%20models%20of%20human%20and%20mouse%20ductal%20pancreatic%20cancer&journal=Cell&doi=10.1016%2Fj.cell.2014.12.021&volume=160&pages=324-38&publication_year=2015&author=Boj%2CSF&author=Hwang%2CC-I&author=Baker%2CLA&author=Chio%2CII&author=Engle%2CDD&author=Corbo%2CV
- How much money does https://doi.org/10.1126%2Fscience.1247125 generate?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Organogenesis%20in%20a%20dish%3A%20modeling%20development%20and%20disease%20using%20organoid%20technologies&journal=Science&doi=10.1126%2Fscience.1247125&volume=345&publication_year=2014&author=Lancaster%2CMA&author=Knoblich%2CJA?
- Discover the revenue of https://doi.org/10.1136%2Fgutjnl-2017-314549
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Human%20gastric%20cancer%20modelling%20using%20organoids&journal=Gut&doi=10.1136%2Fgutjnl-2017-314549&volume=68&pages=207-17&publication_year=2019&author=Seidlitz%2CT&author=Merker%2CSR&author=Rothe%2CA&author=Zakrzewski%2CF&author=Neubeck%2CC&author=Gr%C3%BCtzmann%2CK
- Financial intake of https://doi.org/10.1016%2Fj.stem.2018.09.016
- http://scholar.google.com/scholar_lookup?&title=A%20comprehensive%20human%20gastric%20cancer%20organoid%20biobank%20captures%20tumor%20subtype%20heterogeneity%20and%20enables%20therapeutic%20screening&journal=Cell%20Stem%20Cell&doi=10.1016%2Fj.stem.2018.09.016&volume=23&pages=882-97&publication_year=2018&author=Yan%2CHHN&author=Siu%2CHC&author=Law%2CS&author=Ho%2CSL&author=Yue%2CSSK&author=Tsui%2CWY's financial summary
- What's the revenue for https://doi.org/10.1016%2Fj.jcmgh.2018.09.008?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=An%20organoid-based%20preclinical%20model%20of%20human%20gastric%20cancer&journal=Cell%20Mol%20Gastroenterol%20Hepatol&doi=10.1016%2Fj.jcmgh.2018.09.008&volume=7&pages=161-84&publication_year=2019&author=Steele%2CNG&author=Chakrabarti%2CJ&author=Wang%2CJ&author=Biesiada%2CJ&author=Holokai%2CL&author=Chang%2CJ?
- What's https://doi.org/10.1016%2Fj.cell.2015.03.053's gross income?
- Get to know http://scholar.google.com/scholar_lookup?&title=Prospective%20derivation%20of%20a%20living%20organoid%20biobank%20of%20colorectal%20cancer%20patients&journal=Cell&doi=10.1016%2Fj.cell.2015.03.053&volume=161&pages=933-45&publication_year=2015&author=Wetering%2CM&author=Francies%2CHE&author=Francis%2CJM&author=Bounova%2CG&author=Iorio%2CF&author=Pronk%2CA's earnings
- How much does https://doi.org/10.1038%2Fs41388-020-01492-9 make?
- How much income is http://scholar.google.com/scholar_lookup?&title=Molecular%20biological%20analysis%20of%205-FU-resistant%20gastric%20cancer%20organoids%3B%20KHDRBS3%20contributes%20to%20the%20attainment%20of%20features%20of%20cancer%20stem%20cell&journal=Oncogene&doi=10.1038%2Fs41388-020-01492-9&volume=39&pages=7265-78&publication_year=2020&author=Ukai%2CS&author=Honma%2CR&author=Sakamoto%2CN&author=Yamamoto%2CY&author=Pham%2CQT&author=Harada%2CK earning monthly?
- https://doi.org/10.1074%2Fjbc.M802306200 income
- How much does http://scholar.google.com/scholar_lookup?&title=The%20endocytic%20recycling%20protein%20EHD2%20interacts%20with%20myoferlin%20to%20regulate%20myoblast%20fusion&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.M802306200&volume=283&pages=20252-60&publication_year=2008&author=Doherty%2CKR&author=Demonbreun%2CAR&author=Wallace%2CGQ&author=Cave%2CA&author=Posey%2CAD&author=Heretis%2CK pull in?
- How much revenue does https://doi.org/10.1152%2Fajpcell.00498.2008 generate?
- How much does http://scholar.google.com/scholar_lookup?&title=Myoferlin%20is%20critical%20for%20endocytosis%20in%20endothelial%20cells&journal=Am%20J%20Physiol%20Cell%20Physiol&doi=10.1152%2Fajpcell.00498.2008&volume=297&pages=C484-C92&publication_year=2009&author=Bernatchez%2CPN&author=Sharma%2CA&author=Kodaman%2CP&author=Sessa%2CWC net monthly?
- Revenue of https://doi.org/10.1093%2Fhmg%2F9.2.217
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Myoferlin%2C%20a%20candidate%20gene%20and%20potential%20modifier%20of%20muscular%20dystrophy&journal=Hum%20Mol%20Genet&doi=10.1093%2Fhmg%2F9.2.217&volume=9&pages=217-26&publication_year=2000&author=Davis%2CDB&author=Delmonte%2CAJ&author=Ly%2CCT&author=McNally%2CEM
- Revenue of https://doi.org/10.1242%2Fdev.02155
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Normal%20myoblast%20fusion%20requires%20myoferlin&journal=Development&doi=10.1242%2Fdev.02155&volume=132&pages=5565-75&publication_year=2005&author=Doherty%2CKR&author=Cave%2CA&author=Davis%2CDB&author=Delmonte%2CAJ&author=Posey%2CA&author=Earley%2CJU?
- What are the total earnings of https://doi.org/10.1242%2Fjcs.065375?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Myoferlin%20regulation%20by%20NFAT%20in%20muscle%20injury%2C%20regeneration%20and%20repair&journal=J%20Cell%20Sci&doi=10.1242%2Fjcs.065375&volume=123&pages=2413-22&publication_year=2010&author=Demonbreun%2CAR&author=Lapidos%2CKA&author=Heretis%2CK&author=Levin%2CS&author=Dale%2CR&author=Pytel%2CP earns monthly
- How much does https://doi.org/10.1158%2F0008-5472.CAN-13-1142 generate monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Myoferlin%20is%20a%20key%20regulator%20of%20EGFR%20activity%20in%20breast%20cancer&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-13-1142&volume=73&pages=5438-48&publication_year=2013&author=Turtoi%2CA&author=Blomme%2CA&author=Bellahc%C3%A8ne%2CA&author=Gilles%2CC&author=Hennequi%C3%A8re%2CV&author=Peixoto%2CP net monthly?
- What is the monthly revenue of https://doi.org/10.1038%2Fs41467-018-06179-0?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=A%20small%20molecule%20targeting%20myoferlin%20exerts%20promising%20anti-tumor%20effects%20on%20breast%20cancer&journal=Nat%20Commun&doi=10.1038%2Fs41467-018-06179-0&volume=9&publication_year=2018&author=Zhang%2CT&author=Li%2CJ&author=He%2CY&author=Yang%2CF&author=Hao%2CY&author=Jin%2CW?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Japanese%20classification%20of%20gastric%20carcinoma%3A%203rd%20English%20edition&journal=Gastric%20Cancer&doi=10.1007%2Fs10120-011-0041-5&volume=14&pages=101-12&publication_year=2011 bring in?
- http://scholar.google.com/scholar_lookup?&title=Expression%20and%20function%20of%20Uc.%20160%2B%2C%20a%20transcribed%20ultraconserved%20region%2C%20in%20gastric%20cancer&journal=Gastric%20Cancer&doi=10.1007%2Fs10120-017-0714-9&volume=20&pages=960-9&publication_year=2017&author=Honma%2CR&author=Goto%2CK&author=Sakamoto%2CN&author=Sekino%2CY&author=Sentani%2CK&author=Oue%2CN income
- What's the monthly money flow for https://doi.org/10.1111%2Fcas.12330?
- Get to know http://scholar.google.com/scholar_lookup?&title=MicroRNA-148a%20is%20downregulated%20in%20gastric%20cancer%2C%20targets%20MMP7%2C%20and%20indicates%20tumor%20invasiveness%20and%20poor%20prognosis&journal=Cancer%20Sci&doi=10.1111%2Fcas.12330&volume=105&pages=236-43&publication_year=2014&author=Sakamoto%2CN&author=Naito%2CY&author=Oue%2CN&author=Sentani%2CK&author=Uraoka%2CN&author=Oo%2CHZ's earnings
- What is the earnings of https://doi.org/10.1016%2Fj.devcel.2018.02.013?
- How much does http://scholar.google.com/scholar_lookup?&title=APC%20inhibits%20ligand-independent%20Wnt%20signaling%20by%20the%20clathrin%20endocytic%20pathway&journal=Dev%20Cell&doi=10.1016%2Fj.devcel.2018.02.013&volume=44&pages=566-81.e8&publication_year=2018&author=Saito-Diaz%2CK&author=Benchabane%2CH&author=Tiwari%2CA&author=Tian%2CA&author=Li%2CB&author=Thompson%2CJJ rake in every month?
- What's the financial outcome of https://doi.org/10.18632%2Foncotarget.21688?
- What's http://scholar.google.com/scholar_lookup?&title=Transcribed%20ultraconserved%20region%20Uc.%2063%2B%20promotes%20resistance%20to%20docetaxel%20through%20regulation%20of%20androgen%20receptor%20signaling%20in%20prostate%20cancer&journal=Oncotarget&doi=10.18632%2Foncotarget.21688&volume=8&pages=94259-70&publication_year=2017&author=Sekino%2CY&author=Sakamoto%2CN&author=Goto%2CK&author=Honma%2CR&author=Shigematsu%2CY&author=Sentani%2CK's gross income?
- How much does https://doi.org/10.1111%2Fj.1349-7006.2012.02353.x pull in monthly?
- How much profit is http://scholar.google.com/scholar_lookup?&title=Liver-intestine%20cadherin%20induction%20by%20epidermal%20growth%20factor%20receptor%20is%20associated%20with%20intestinal%20differentiation%20of%20gastric%20cancer&journal=Cancer%20Sci&doi=10.1111%2Fj.1349-7006.2012.02353.x&volume=103&pages=1744-50&publication_year=2012&author=Sakamoto%2CN&author=Oue%2CN&author=Sentani%2CK&author=Anami%2CK&author=Uraoka%2CN&author=Naito%2CY making per month?
- How much money does https://doi.org/10.1038%2Fnature07935 generate?
- How much money does http://scholar.google.com/scholar_lookup?&title=Single%20Lgr5%20stem%20cells%20build%20crypt-villus%20structures%20in%20vitro%20without%20a%20mesenchymal%20niche&journal=Nature&doi=10.1038%2Fnature07935&volume=459&pages=262-5&publication_year=2009&author=Sato%2CT&author=Vries%2CRG&author=Snippert%2CHJ&author=Wetering%2CM&author=Barker%2CN&author=Stange%2CDE make?
- What's the financial gain of https://doi.org/10.1038%2Fs41419-018-1236-z?
- http://scholar.google.com/scholar_lookup?&title=ATXN2L%20upregulated%20by%20epidermal%20growth%20factor%20promotes%20gastric%20cancer%20cell%20invasiveness%20and%20oxaliplatin%20resistance&journal=Cell%20Death%20Dis&doi=10.1038%2Fs41419-018-1236-z&volume=10&pages=1-13&publication_year=2019&author=Lin%2CL&author=Li%2CX&author=Pan%2CC&author=Lin%2CW&author=Shao%2CR&author=Liu%2CY's financial summary
- What's the financial gain of https://doi.org/10.18632%2Foncotarget.18208?
- How much does http://scholar.google.com/scholar_lookup?&title=EphA2%20affects%20the%20sensitivity%20of%20oxaliplatin%20by%20inducing%20EMT%20in%20oxaliplatin-resistant%20gastric%20cancer%20cells&journal=Oncotarget&doi=10.18632%2Foncotarget.18208&volume=8&pages=47998-8011&publication_year=2017&author=Wen%2CQ&author=Chen%2CZ&author=Chen%2CZ&author=Chen%2CJ&author=Wang%2CR&author=Huang%2CC earn?
- https://doi.org/10.1038%2Fonc.2016.369's financial summary
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Myoferlin%20regulates%20cellular%20lipid%20metabolism%20and%20promotes%20metastases%20in%20triple-negative%20breast%20cancer&journal=Oncogene&doi=10.1038%2Fonc.2016.369&volume=36&pages=2116-30&publication_year=2017&author=Blomme%2CA&author=Costanza%2CB&author=Tullio%2CP&author=Thiry%2CM&author=Simaeys%2CG&author=Boutry%2CS?
- Income figures for https://doi.org/10.1111%2Fjcmm.13455
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Down-regulating%20myoferlin%20inhibits%20the%20vasculogenic%20mimicry%20of%20melanoma%20via%20decreasing%20MMP-2%20and%20inducing%20mesenchymal-to-epithelial%20transition&journal=J%20Cell%20Mol%20Med&doi=10.1111%2Fjcmm.13455&volume=22&pages=1743-54&publication_year=2018&author=Zhang%2CW&author=Zhou%2CP&author=Meng%2CA&author=Zhang%2CR&author=Zhou%2CY
- How much does https://doi.org/10.1158%2F1535-7163.MCT-14-0636 generate monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Tumor-related%20molecular%20mechanisms%20of%20oxaliplatin%20resistance&journal=Mol%20Cancer%20Ther&doi=10.1158%2F1535-7163.MCT-14-0636&volume=14&pages=1767-76&publication_year=2015&author=Martinez-Balibrea%2CE&author=Mart%C3%ADnez-Card%C3%BAs%2CA&author=Gin%C3%A9s%2CA&author=Ruiz%20de%20Porras%2CV&author=Moutinho%2CC&author=Layos%2CL pull in monthly?
- How much income does https://doi.org/10.1124%2Fmol.58.5.920 have?
- How much money does http://scholar.google.com/scholar_lookup?&title=Oxaliplatin-induced%20damage%20of%20cellular%20DNA&journal=Mol%20Pharmacol&doi=10.1124%2Fmol.58.5.920&volume=58&pages=920-27&publication_year=2000&author=Woynarowski%2CJM&author=Faivre%2CS&author=Herzig%2CMC&author=Arnett%2CB&author=Chapman%2CWG&author=Trevino%2CAV generate?
- Get to know what's the income of https://doi.org/10.1038%2Fnm.4291
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=A%20subset%20of%20platinum-containing%20chemotherapeutic%20agents%20kills%20cells%20by%20inducing%20ribosome%20biogenesis%20stress&journal=Nat%20Med&doi=10.1038%2Fnm.4291&volume=23&pages=461-71&publication_year=2017&author=Bruno%2CPM&author=Liu%2CY&author=Park%2CGY&author=Murai%2CJ&author=Koch%2CCE&author=Eisen%2CTJ?
- Get to know https://doi.org/10.1016%2Fj.bcp.2009.12.002's earnings
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Increased%20levels%20and%20defective%20glycosylation%20of%20MRPs%20in%20ovarian%20carcinoma%20cells%20resistant%20to%20oxaliplatin&journal=Biochem%20Pharmacol&doi=10.1016%2Fj.bcp.2009.12.002&volume=79&pages=1108-17&publication_year=2010&author=Beretta%2CGL&author=Benedetti%2CV&author=Cossa%2CG&author=Assaraf%2CYG&author=Bram%2CE&author=Gatti%2CL?
- How much does https://citation-needed.springer.com/v2/references/10.1007/s10120-021-01206-4?format=refman&flavour=references gross monthly?
- Learn how profitable https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kenji%20Harada is on a monthly basis
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kenji%20Harada%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in monthly?
- What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Naoya%20Sakamoto each month?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Naoya%20Sakamoto%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's total income per month
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shoichi%20Ukai make?
- What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shoichi%20Ukai%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yusuke%20Yamamoto
- Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yusuke%20Yamamoto%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Quoc%20Thang%20Pham?
- What's the financial outcome of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Quoc%20Thang%20Pham%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- See how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Daiki%20Taniyama makes per month
- How much income does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Daiki%20Taniyama%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ririno%20Honma earn?
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ririno%20Honma%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ryota%20Maruyama income
- Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ryota%20Maruyama%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much cash flow does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tsuyoshi%20Takashima have monthly?
- How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tsuyoshi%20Takashima%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
- What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hiroshi%20Ota?
- Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hiroshi%20Ota%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yuki%20Takemoto
- What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yuki%20Takemoto%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kazuaki%20Tanabe income
- How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kazuaki%20Tanabe%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
- Explore the financials of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hideki%20Ohdan
- What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hideki%20Ohdan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Wataru%20Yasui pull in?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Wataru%20Yasui%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
- How much cash flow does https://static-content.springer.com/esm/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_MOESM1_ESM.xlsx have monthly?
- See how much https://static-content.springer.com/esm/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_MOESM2_ESM.pdf makes per month
- How much does https://s100.copyright.com/AppDispatchServlet?title=Establishment%20of%20oxaliplatin-resistant%20gastric%20cancer%20organoids%3A%20importance%20of%20myoferlin%20in%20the%20acquisition%20of%20oxaliplatin%20resistance&author=Kenji%20Harada%20et%20al&contentID=10.1007%2Fs10120-021-01206-4©right=The%20International%20Gastric%20Cancer%20Association%20and%20The%20Japanese%20Gastric%20Cancer%20Association&publication=1436-3291&publicationDate=2021-07-16&publisherName=SpringerNature&orderBeanReset=true earn?
- How much does https://crossmark.crossref.org/dialog/?doi=10.1007/s10120-021-01206-4 net monthly?
- Learn about the earnings of https://citation-needed.springer.com/v2/references/10.1007/s10120-021-01206-4?format=refman&flavour=citation
- Monthly income for https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
- What's the financial outcome of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research?
- How much does https://www.springernature.com/gp/products net monthly?
- How much cash flow does https://www.springernature.com/gp/librarians have monthly?
- How much money does https://www.springernature.com/gp/societies make?
- Earnings of https://www.springernature.com/gp/partners
- What is the earnings of https://www.springer.com/?
- What is the monthly revenue of https://www.nature.com/?
- How much revenue does https://www.biomedcentral.com/ produce monthly?
- Learn how profitable https://www.palgrave.com/ is on a monthly basis
- Get to know https://www.apress.com/'s earnings
- What's the monthly money flow for https://www.springernature.com/gp/legal/ccpa?
- Learn how profitable https://www.springernature.com/gp/info/accessibility is on a monthly basis
- Profit of https://support.springernature.com/en/support/home
- Profit of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations
- How much revenue does https://www.springernature.com/ generate?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref